Strengthen Disease Surveillance for At-Risk Respiratory Patients— from Hospital to Home

The RESP® Platform

Remote Respiratory Monitoring: RESP Biosensor

Technology Overview

The RESP® platform offers clinical teams a novel, proactive way to manage patients with chronic respiratory diseases, helping to identify changes earlier and reduce exacerbation and re-admission risk.

Continuous and passive lung sound monitoring to extend the range of stethoscope auscultation and in-person assessments¹
Patient-friendly form factor with consistently positive patient feedback²
Comprehensive reporting and alerts for potential exacerbations

1. Equivalent performance to 3M Littman 3200 Electronic Stethoscope (source)
2. Survey results from 2024 research collaboration with Lurie Children’s and other clinical trials (source)

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Interested in a Research Collaboration?

We’re seeking clinical and academic collaborators to explore how our technology can improve patient outcomes.
Partners may be eligible for in-kind support.

Learn More

RESP® Platform Care Settings

Home Monitoring

Remote monitoring of at-risk COPD & Asthma patients
Interstitial lung diseases
Heart failure
Pulmonary Rehabilitation

Acute Care

In-patient status monitoring
Chronic, complex care management
Hospital at Home
Tele-ICUs

Post-Acute Care

Post-discharge hospital to home
Post-surgical recovery and rehabilitation
Skilled-nursing and long-term care facilities

Remote Monitoring Practice Application

At-risk COPD patient is discharged from hospital

Patient is prescribed RESP® Biosensor for two weeks

On day 5, clinician receives alert of increased coughing and wheezing

Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission

Potential to Detect Exacerbations Earlier¹

1. Case Study of an adult AE-COPD patient using the RESP Biosensor. Einstein Hospital, Philadelphia. https://journal.chestnet.org/article/S0012-3692(23)04216-2/fulltext

Seamlessly Monitor Respiratory Patients Remotely

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.